We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIAV icon
1026
Viavi Solutions
VIAV
$8.51B
$1.29M ﹤0.01%
187,457
+187,267
+98,562% +$1.46M
SYF icon
1027
Synchrony
SYF
$24.4B
$1.28M ﹤0.01%
27,210
+8,732
+47% +$379K
PRIM icon
1028
Primoris Services
PRIM
$4.14B
$1.28M ﹤0.01%
25,631
-48
-0.2% -$2.38K
MGNX icon
1029
MacroGenics
MGNX
$260M
$1.28M ﹤0.01%
300,499
-153,233
-34% -$1.49M
ONTO icon
1030
Onto Innovation
ONTO
$12B
$1.28M ﹤0.01%
5,816
-430
-7% -$88.9K
LUMN icon
1031
Lumen
LUMN
$6.88B
$1.27M ﹤0.01%
1,155,375
-303,377
-21% -$385K
ELF icon
1032
e.l.f. Beauty
ELF
$5.51B
$1.27M ﹤0.01%
6,009
-112,881
-95% -$20.1M
OEC icon
1033
Orion
OEC
$325M
$1.26M ﹤0.01%
57,543
+7,663
+15% +$184K
CORT icon
1034
Corcept Therapeutics
CORT
$12.1B
$1.26M ﹤0.01%
38,759
-11,147
-22% -$305K
UAA icon
1035
Under Armour
UAA
$2.15B
$1.26M ﹤0.01%
188,609
+11,961
+7% +$81.6K
ITT icon
1036
ITT
ITT
$17.4B
$1.26M ﹤0.01%
9,737
-469
-5% -$61.6K
RVLV icon
1037
Revolve Group
RVLV
$1.47B
$1.26M ﹤0.01%
78,934
+5,251
+7% +$100K
PNTG icon
1038
Pennant Group
PNTG
$1.48B
$1.25M ﹤0.01%
54,045
+46,324
+600% +$1.02M
EGP icon
1039
EastGroup Properties
EGP
$10.6B
$1.25M ﹤0.01%
7,346
+486
+7% +$80.3K
TOL icon
1040
Toll Brothers
TOL
$12.2B
$1.24M ﹤0.01%
10,723
-553
-5% -$66.9K
SUPN icon
1041
Supernus Pharmaceuticals
SUPN
$2.41B
$1.23M ﹤0.01%
46,128
-152
-0.3% -$4.41K
NLY icon
1042
Annaly Capital Management
NLY
$16B
$1.23M ﹤0.01%
64,505
-3,223
-5% -$62.6K
MD icon
1043
Pediatrix Medical
MD
$2.12B
$1.23M ﹤0.01%
162,532
-64,702
-28% -$535K
FUTU icon
1044
Futu Holdings
FUTU
$15.4B
$1.2M ﹤0.01%
18,227
+16,066
+743% +$1.09M
SNV
1045
DELISTED
Synovus
SNV
$1.19M ﹤0.01%
29,688
-2,577
-8% -$97.7K
TDOC icon
1046
Teladoc Health
TDOC
$1.17B
$1.19M ﹤0.01%
121,654
+7,549
+7% +$92.1K
TBBK icon
1047
The Bancorp
TBBK
$2.07B
$1.18M ﹤0.01%
31,359
-18,035
-37% -$596K
WRK
1048
DELISTED
WestRock Company
WRK
$1.18M ﹤0.01%
23,488
-8,989
-28% -$454K
GDOT icon
1049
Green Dot
GDOT
$756M
$1.18M ﹤0.01%
124,669
+7,532
+6% +$70K
ARCB icon
1050
ArcBest
ARCB
$2.91B
$1.17M ﹤0.01%
10,929
+330
+3% +$39.8K

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.